The longevity advisory
We help longevity brands close the distance between groundbreaking science and the people it was built to reach.
ExploreWhy this advisory is different
Our advisory panel isn't watching the longevity space from the sidelines. They're building it. They are scientists, entrepreneurs, and ecosystem builders shaping where the field goes next. That depth of expertise gives you an edge in a market where credibility and evidence matter.
We bring deep experience in branding, growth marketing, and commercial pull-through across Asia-Pacific, Europe, and North America, with direct experience in regulated, science-led categories. We don't just provide consulting support. We roll up our sleeves and help execute.
The longevity space has no shortage of brilliant scientists or talented marketers. What it lacks are people who sit at the intersection of both, who understand the science and know how to turn it into brand stories that earn trust, drive discovery, and turn curious sceptics into believers.
If you’re building a longevity brand and want to build credibility, not just visibility, you’re in the right place.
Who we are
FounderNoriko brings deep expertise at the intersection of brand strategy, advertising, and AI-native marketing infrastructure. She is the co-founder of Findabl (3cubed.ai), an AI Citation Intelligence Platform that tracks and optimises how brands are cited and surfaced across large language models.
She is also an advisor to Longevity Global and co-host of the Aging Code Summit, giving the advisory direct roots in the scientific and broader longevity ecosystem.
Her work sits at the heart of the advisory's core thesis: in a category where trust is hard won, visibility in AI is not a future consideration. It is already shaping how people discover, evaluate, and trust longevity brands. Noriko brings the technical understanding of how AI discovery works and the strategic experience to turn it into action.
Co-FounderSushmita spent over twenty years building growth marketing functions inside companies that don't accept vanity metrics, including McKinsey, PwC, Skyscanner, PropertyGuru, and Reckitt.
She founded Krux, an AI-led growth marketing firm built on that same rigor. Krux operates on a Build, Operate, Transfer model: design the engine, run it with accountability, then hand it back fully operational.
The longevity advisory brings that experience to a category she believes is ready to break through. One that needs both scientific credibility and the commercial infrastructure to reach the people it was built to help.
What we offer
From evidence to attention. From first market entry to lasting credibility.
Longevity is where some of the most exciting innovation is happening. But as with any fast-growing field, there is a lot of innovation and not yet a lot of consensus. That creates a real need for education, awareness building, and credible thought leadership that helps people understand the science, the possibilities, and what actually matters.
Our strategy starts with the science and builds toward the market, not the other way around. We develop brand positioning, SEO and GEO, content, and channel strategy specifically for companies across the longevity spectrum. This is not generic marketing applied to longevity. It is marketing built from inside the category out.
We advise longevity companies on market entry, competitive positioning, and stakeholder mapping, particularly those entering the US market. Global companies need more than translation. They need to understand the regulatory environment, existing pathways to market, the stakeholders who influence adoption, and how trust is built.
We help companies develop authority signals, trust, and credibility.
We also build the discoverability infrastructure behind them. When a clinician, journalist, investor, or potential partner searches for companies in your category, what do they find? We help you show up where decisions are being shaped, across traditional search, AI search, scientific databases, analyst reports, and media.
A Scientific Advisory Board is only as strong as the people around the table. For many longevity companies, the challenge is gaining access to leading scientists and clinicians in the field. The right advisors bring scientific authority, strengthen credibility with investors and partners, and can open doors across the longevity ecosystem.
Through the Longevity Global network, spanning researchers, clinicians, geroscientists, and translational scientists across 22+ global chapters and institutions including MIT, Stanford, the Buck Institute, NYU, and Columbia, we provide access to people at the forefront of longevity science.
That network extends beyond Scientific Advisory Boards. The right introduction to a researcher, clinician, investor, or strategic partner can change the trajectory of a company. We help make those connections.
Our advisors
Every claim in longevity gets scrutinised. We think that’s exactly right. Marketing in this category requires scientific accountability, and building a successful business requires real-world commercial expertise.
Our advisory board brings both.
Founder & CEO, NeuroAge Therapeutics
Founder & Executive Director, Longevity Global
Christin is a neuroscientist, physician, and one of the most connected builders in the longevity space. She completed her postdoctoral training at MIT and holds an MD and PhD in Neuroscience from the University of Pittsburgh. As CEO of NeuroAge Therapeutics, she is advancing therapeutics targeting brain aging, one of the field's most pressing and commercially underserved challenges.
She founded Longevity Global, the nonprofit that runs longevity chapters and summits across San Francisco, New York, Boston, London, San Diego, Chicago, and beyond, a network that sits at the centre of where longevity science and commercial investment meet.
Christin advises on scientific credibility, category framing, and the emerging clinical landscape that longevity brands need to understand to operate with integrity.
Longevity Global
Boston Chapter
Justin leads the Boston chapter of Longevity Global, one of the most active nodes in the global longevity community, convening researchers, investors, founders, and clinicians at the intersection of aging science and commercial application.
He brings on-the-ground intelligence from the longevity conference and community circuit: who is building what, where capital is moving, and what the research community actually thinks of commercial longevity claims. In a space where credibility is everything, Justin provides a direct read on what earns trust inside the longevity community itself.
Let’s build this together
If you're a longevity founder, investor, or clinical brand ready to close the gap between your science and your market, we'd like to talk. No pitch decks required for the first conversation.
Get in touchAdvisory engagements are selective. We work with a small number of clients at a time so we can stay close to the work and deliver at the level each engagement requires.